🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Treatment Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.

Several experts stated the popularity for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Service Response and Content Elimination

According to TikTok, the service has removed problematic content and prohibited associated hashtags and query recommendations. The organization stated it was dedicated to keeping the service secure and investing in enhancing compliance measures.

Online Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, positive reviews and step-by-step guides for mixing or injecting at residence.

After moments of entering one group, a vendor shared WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.

Product Information and Pricing

Inside these communities, messages show dark colored packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it regularly monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already seen patients harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially significant medical dangers”.